Stroke and Vascular Neurology

Article	Citations
Oxidised low-density lipoprotein and adverse outcome in patients with acute mild ischaemic stroke or high-risk TIA: a secondary analysis of the INSPIRES randomised clinical trial	215
Updates on vascular dementia	70
Efficacy and safety of Ferrous iron on the prevention of Vascular cOgnitive impaiRment among patients with cerebral Infarction/TIA (FAVORITE): rationale and design of a multicentre randomised trial	48
Treating acute large vessel occlusion stroke: to bridge or not to bridge?	47
Chinese stroke association guidelines on reperfusion therapy for acute ischaemic stroke 2024	44
Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study	37
Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: the MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOto	35
Exosomes-mediated delivery of miR-486-3p alleviates neuroinflammation via SIRT2-mediated inhibition of mitophagy after subarachnoid hemorrhage	29
Multicentre prospective, randomised open-label, endpoint-blinded study to evaluate the safety and efficacy of propranolol for the prevention of stroke-associated pneumonia in patients with intracerebr	29
Association ofAPOEgenotype with CT markers of cerebral amyloid angiopathy in spontaneous intracerebral haemorrhage	28
Photochemically induced thalamus infarction impairs cognition in a mouse model	26
Real-world evaluation of Brainomix e-Stroke software	25
Mass effect, aneurysms and flow diverters: Is the pipeline embolization device the Lone Virtuoso? Commentary on ‘Pipeline embolization device for intracranial aneurysms presenting with mass effect: a	23
Quantitative angiographic haemodynamic evaluation of bypasses for complex aneurysms: a preliminary study	22
Advance Consent for participation in Acute Stroke Trials (ACTION): protocol for a feasibility study	22
Intelligent cholinergic white matter pathways algorithm based on U-net reflects cognitive impairment in patients with silent cerebrovascular disease	21
Stenting for symptomatic intracranial arterial stenosis with different qualifying arteries: a preplanned pooled individual patient data analysis	21
Definitions of white matter hyperintensity change: impact on estimates of progression and regression	21
Vascular dementia has the highest hospitalisation rate in China: a nationwide hospital information system study	21
Treatment practice of vasospasm during endovascular thrombectomy: an international survey	20
ADVISING score: a reliable grading scale based on injury and response for intracerebral haemorrhage	19
Dural sinus septum: an underlying cause of cerebral venous sinus stenting failure and complications	19
Discrepancies between clinical and autopsy findings in patients who had an acute stroke	19
Development of a deep learning method to identify acute ischaemic stroke lesions on brain CT	18
Gut Microbiome and Stroke: a Bidirectional Mendelian Randomisation Study in East Asian and European Populations	18

Analytical validation of GMEX rapid point-of-careCYP2C19genotyping system for the CHANCE-2 trial	18
Trendelenburg position for acute anterior circulation ischaemic stroke with large artery atherosclerosis aetiology (HOPES 3): rationale and design	18
Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study	18
Cumulative burden of lipid profiles predict future incidence of ischaemic stroke and residual risk	18
Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease	17
Clinical imaging factors of excellent outcome after thrombolysis in large-vessel stroke: a THRACE subgroup analysis	17
Prediction of large vessel occlusion for ischaemic stroke by using the machine learning model random forests	17
Intra-arterial tenecteplase during thrombectomy for acute stroke (BRETIS-TNK II): rationale and design	16
Mechanical thrombectomy with combined stent retriever and contact aspiration versus stent retriever alone for acute large vessel occlusion: data from ANGEL-ACT registry	16
Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications	16
Magnitude of systolic blood pressure reduction following endovascular treatment and clinical outcomes in acute large artery occlusion stroke	15
Remote ischaemic conditioning for stroke: unanswered questions and future directions	15
Effects and safety of aspirin use in patients after cerebrovascular bypass procedures	14
Genome sequencing reveals the role of rare genomic variants in Chinese patients with symptomatic intracranial atherosclerotic disease	14
MetS in the prediction of asymptomatic intracranial arterial stenosis: the potential mediating role of hsCRP	14
Haemorrhage risk of brain arteriovenous malformation during pregnancy and puerperium	14
Prediction of futile recanalisation after endovascular treatment in acute ischaemic stroke: development and validation of a hybrid machine learning model	14
Associations of HDL-C/LDL-C with myocardial infarction, all-cause mortality, haemorrhagic stroke and ischaemic stroke: a longitudinal study based on 384 093 participants from the UK Biobank	14
Cerebral venous sinus thrombosis: changing trends in the incidence, age and gender (findings from the CMC Vellore CVT registry)	14
Response to ‘comments on the article ‘sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections’’	13
DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial	12
Novel role of STAT3 in microglia-dependent neuroinflammation after experimental subarachnoid haemorrhage	12
Loss of life expectancy due to stroke and its subtypes in urban and rural areas in China, 2005–2020	11
Rationale and Study Design to Assess the Efficacy and Safety of Minocycline in Patients with Moderate to Severe Acute Ischaemic Stroke (EMPHASIS)	11
Functional status at 30 and 90 days after mild ischaemic stroke	11
Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial	11
Efficacy and safety of a neurointerventional operation robotic assistance system in cerebral angiography	11
Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries	11
Early cisternal fibrinolysis is more effective than rescue spasmolysis for the prevention of delayed infarction after subarachnoid haemorrhage	11
Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial	10
Would integrated Western and traditional Chinese medicine have more benefits for stroke rehabilitation? A systematic review and meta-analysis	10
Acute right insular ischaemic lesions and poststroke left ventricular dysfunction	10
Optimal duration of dual antiplatelet therapy for minor stroke within 72 hours of symptom onset: a prospective cohort study	10
Oestrogen ameliorates blood-brain barrier damage after experimental subarachnoid haemorrhage via the SHH pathway in male rats	10
Surgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations	10
Association of fluid-attenuated inversion recovery vascular hyperintensity with ischaemic events in internal carotid artery or middle cerebral artery occlusion	9
Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)	9
When treating acute ischaemic stroke of LVO type, time window prevails over tissue window	9
New rat model of spinal cord infarction with long-lasting functional disabilities generated by intraspinal injection of endothelin-1	9
Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea	9
Prospective, multicentre study of screening, investigation and management of hyponatraemia after subarachnoid haemorrhage in the UK and Ireland	8
A Mendelian randomisation, propensity score matching study to investigate causal association between serum homocysteine and intracranial aneurysm	8
Understanding external carotid artery collateralisation after cerebral revascularisation in moyamoya disease: insights from quantitative analysis	8
Prevalence and risk factors of stroke in China: a national serial cross-sectional study from 2003 to 2018	8
Editorial: minor stroke is not minor	8
Characteristics, temporal trends and outcomes of intravenous thrombolysis in Chinese patients aged>80 years who had a stroke	8
Intra-arterial tenecteplase after successful endovascular therapy (ANGEL-TNK): protocol of a multicentre, open-label, blinded end-point, prospective, randomised trial	8
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial	8
KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway	8
Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISR	8

In patients who had a stroke or TIA, enlarged perivascular spaces in basal ganglia may cause future haemorrhagic strokes	8
Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel	8
Comparison of the Pipeline embolisation device alone or combined with coiling for treatment of different sizes of intracranial aneurysms	7
Night-time diastolic blood pressure variability relates to stroke recurrence in patients who had ischaemic stroke with small artery occlusion	7
White matter disease derived from vascular and demyelinating origins	7
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial	7
Asymptomatic carotid artery stenosis is associated with increased Alzheimer’s disease and non-Alzheimer’s disease dementia risk	7
Efficacy of butylphthalide in preventing cognitive decline in ischaemic stroke survivors: a 12-month prospective following-up study	7
Reperfusion and cytoprotective agents are a mutually beneficial pair in ischaemic stroke therapy: an overview of pathophysiology, pharmacological targets and candidate drugs focusing on excitotoxicity	7
Roles of light transmission aggregometry and CYP2C19 genotype in predicting ischaemic complications during interventional therapy for intracranial aneurysms	7
CSA declaration of next-generation reperfusion therapy for ischaemic stroke	7
Association between coexisting intracranial artery and extracranial carotid artery atherosclerotic diseases and ipsilateral cerebral infarction: a Chinese Atherosclerosis Risk Evaluation (CARE-II) stu	7
Haemostatic therapy in spontaneous intracerebral haemorrhage patients with high-risk of haematoma expansion by CT marker: a systematic review and meta-analysis of randomised trials	7
Exploring the relationship between embolic acute stroke distribution and supra-aortic vessel patency: key findings from an in vitro model study	7
Antiplatelet therapy versus intravenous thrombolysis for mild acute ischaemic stroke: a living systematic review and meta-analysis	7
Penumbra-targeted CircOGDH siRNA-loaded nanoparticles alleviate neuronal apoptosis in focal brain ischaemia	7
Left atrial appendage closure for patients with atrial fibrillation at high intracranial haemorrhagic risk	7
Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial	7
Prevalence, genetic and clinical characteristics in first-degree relatives of patients with familial cerebral cavernous malformations in China	6
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke Tenecteplase II (CHABLIS-T II): rationale and design	6
Comparative effectiveness of combined antiplatelet treatments in acute minor ischaemic stroke	6
Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects	6
Sodium and water perturbations in patients who had an acute stroke: clinical relevance and management strategies for the neurologist	6
Distribution and prognosis of acute ischaemic stroke with negative diffusion-weighted imaging	6
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats	6
Group 2 innate lymphoid cells resolve neuroinflammation following cerebral ischaemia	6
Cisternostomy for malignant middle cerebral artery infarction: proposed pathophysiological mechanisms and preliminary results	6
Precision antiplatelet therapy for the prevention of ischaemic stroke	6
Endovascular treatment for basilar artery occlusion: a meta-analysis	6
Clinical and radiological features of medullary infarction caused by spontaneous vertebral artery dissection	5
Bone marrow-derived mesenchymal stem cell ameliorates post-stroke enterobacterial translocation through liver-gut axis	5
Characteristics of intracranial plaque in patients with non-cardioembolic stroke and intracranial large vessel occlusion	5
Neglected Mendelian causes of stroke in adult Chinese patients who had an ischaemic stroke or transient ischaemic attack	5
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-	5
Endovascular thrombectomy with or without intravenous alteplase for acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis of randomized trials	5
Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well: results from the MR CLEAN Registry	5
Dl-3-n-butylphthalide attenuates brain injury caused by cortical infarction accompanied by cranial venous drainage disturbance	5
Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis (BASIS): protocol of a prospective, multicentre, randomised, controlled trial	5
Circulating immune cell landscape in patients who had mild ischaemic stroke	5
Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial	5
SomaticGJA4mutation in intracranial extra-axial cavernous hemangiomas	5
Association between stroke subtypes and outcomes of endovascular therapy: a post-hoc analysis of the ANGEL-ASPECT Trial	5
Venous thromboembolism among Medicare acute ischaemic stroke patients with and without COVID-19	5
TIMP1 protects against blood-brain barrier disruption after subarachnoid haemorrhage by inhibiting ubiquitination of astrocytic β1-integrin	5
AHORA: a Spanish language tool to identify acute stroke symptoms	5
Intra-arterial thrombolytics during endovascular thrombectomy for acute ischaemic stroke in the MR CLEAN Registry	5
Inhibition of the postsynaptic density protein 95 on the protective effect of Ang-(1-7)–Mas on cerebral ischaemia injury	5
Thrombus migration in patients with acute ischaemic stroke undergoing endovascular thrombectomy	5
Improved functional outcome for stroke patients with low ASPECTS score large core infarctions: 1-year follow-up of three randomised trials	5
Combined effect of cortical superficial siderosis and cerebral microbleed on short-term and long-term outcomes after intracerebral haemorrhage	5
Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial	5
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial	5
Is more evidence needed for thrombectomy in basilar artery occlusion? The BASICS and BEST meta-analytical approaches	5
IRIS, a randomised, double-blind, placebo-controlled trial of interleukin-6 receptor inhibition undergoing endovascular treatment in acute anterior circulation ischaemic stroke: study rationale and de	5
Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy	5
White matter hyperintensity progression is associated with incident probable dementia or mild cognitive impairment	4
Frequency, predictors and cardiovascular outcomes associated with transthoracic echocardiographic findings during acute ischaemic stroke hospitalisation	4
Associations of polygenic risk scores with risks of stroke and its subtypes in Chinese	4
Clinical implications of haemodynamics in symptomatic intracranial atherosclerotic stenosis by computational fluid dynamics modelling: a systematic review	4
Efficacy and safety of early anticoagulation after endovascular treatment in patients with atrial fibrillation	4
Clinician’s perspectives in using head impulse-nystagmus-test of skew (HINTS) for acute vestibular syndrome: UK experience	4
Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort	4
Thrombus iodine-based perviousness is associated with recanalisation and functional outcomes in endovascular thrombectomy	4
Prestroke physical activity is associated with admission haematoma volume and the clinical outcome of intracerebral haemorrhage	4
Time to treat the climate and nature crisis as one indivisible global health emergency	4
Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial	4
Detailed phenotype ofRNF213p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack	4
Cisternal and intraventricular irrigation in subarachnoid and intraventricular haemorrhage	4
COP27 climate change conference: urgent action needed for Africa and the world	3
Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials	3
Altered excitability of motor neuron pathways after stroke: more than upper motor neuron impairments	3
Protective effects of melatonin on stroke in diabetic mice: central and peripheral inflammation modulation	3
Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inf	3
NOTCH2NLCexpanded GGC repeats in patients with cerebral small vessel disease	3
Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study	3
Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamics	3
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines	3
Thrombolysis for ischaemic stroke despite direct oral anticoagulation	3
One-year direct and indirect costs of ischaemic stroke in China	3
Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study	3

Left atrial appendage closure in patients with atrial fibrillation and acute ischaemic stroke despite anticoagulation	3
Discontinuation of antiplatelet therapy after stent-assisted coil embolisation of cerebral aneurysm: a nationwide cohort study	3
Low-intensity focused ultrasound stimulation promotes stroke recovery via astrocytic HMGB1 and CAMK2N1 in mice	3
Role of histone deacetylases and sirtuins in the ischaemic stroke: a protocol for a systematic review and meta-analysis of animal studies	3
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study	3
LRRC8A in endothelial cells contributes to the aberrant blood-brain barrier integrity in ischaemic stroke	3
Poststroke motor, cognitive and speech rehabilitation with brain–computer interface: a perspective review	3
VasCog Screen test: sensitive in detecting cognitive impairment in patients who had a stroke or with heart failure	3
0.23-Tesla MRI to differentiate between ischaemic and haemorrhagic strokes within 24 hours of onset: a combined experimental–clinical study	3
Real-world analysis of two ischaemic stroke and TIA systolic blood pressure goals on 12-month mortality and recurrent vascular events	3
Revascularisation patterns and characteristics after erythropoietin pretreatment and multiple burr holes in patients who had acute stroke with perfusion impairment	3
Patient-reported outcome measure and its application in patients with stroke: item response theory	3